Rivaroxaban with or without aspirin in stable cardiovascular disease

dc.catalogadoryvc
dc.contributor.authorEikelboom, J. W.
dc.contributor.authorConnolly, S. J.
dc.contributor.authorBosch, J.
dc.contributor.authorDagenais, G. R.
dc.contributor.authorHart, R. G.
dc.contributor.authorShestakovska, O.
dc.contributor.authorDiaz, R.
dc.contributor.authorAlings, M.
dc.contributor.authorLonn, E. M.
dc.contributor.authorAnand, S. S.
dc.contributor.authorWidimsky, P.
dc.contributor.authorHori, M.
dc.contributor.authorAvezum, A.
dc.contributor.authorPiegas, L. S.
dc.contributor.authorBranch, K. R. H.
dc.contributor.authorProbstfield, J.
dc.contributor.authorBhatt, D. L.
dc.contributor.authorZhu, J.
dc.contributor.authorLiang, Y.
dc.contributor.authorVerdejo Pinochet, Hugo
dc.contributor.otherCardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS)
dc.date.accessioned2024-01-03T21:09:20Z
dc.date.available2024-01-03T21:09:20Z
dc.date.issued2017
dc.fuente.origenORCID
dc.identifier.doi10.1056/NEJMoa1709118
dc.identifier.pubmedid28844192
dc.identifier.urihttps://doi.org/10.1056/NEJMoa1709118
dc.identifier.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-85029804845&partnerID=MN8TOARS
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/75618
dc.information.autorucEscuela de Medicina; Verdejo Pinochet, Hugo Eduardo; 0000-0003-0078-4792; 1001175
dc.issue.numero14
dc.language.isoen
dc.nota.accesoContenido parcial
dc.publisherMassachussetts Medical Society
dc.revistaNew England Journal of Medicine
dc.rightsacceso restringido
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.titleRivaroxaban with or without aspirin in stable cardiovascular disease
dc.typeartículo
dc.volumen377
sipa.codpersvinculados1001175
sipa.trazabilidadORCID;2024-01-01
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
RESUMEN_Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.pdf
Size:
107.57 KB
Format:
Adobe Portable Document Format
Description: